Italian Genetic Study on Familial Hypercholesterolemia and Other Genetic Blood Lipid Disorders LIPIGEN

What this Trial Is About

Researchers are conducting the LIPIGEN observational study to better understand diseases related to blood lipid levels, such as familial hypercholesterolaemia FH and other genetic dyslipidaemias. The study involves Italian physicians and researchers who aim to improve diagnosis and treatment by collecting detailed patient information and analyzing genetic causes. This research may help identify the most effective treatments and monitor long-term health outcomes. Participants continue their usual clinical care while the study collects data from their medical records, family history, and genetic testing without adding extra procedures. In some cases, additional evaluations like ultrasounds may be performed to better assess the condition. The study involves more than 50 centers across Italy, making it accessible to many individuals with these conditions. Throughout the study, researchers will evaluate patients lipid and genetic profiles at baseline and observe treatment adherence, cardiovascular events, and other important health outcomes over time. Participants involvement includes regular clinical visits and data collection as part of standard care. The study began in 2015 and will continue through 2026, aiming to enhance personalized diagnosis and treatment strategies for genetic lipid disorders.

Lipid Transport Disorder Italian Genetic Record (LIPIGEN)